FinVector Oy is a growing pharmaceutical company authorized by FIMEA, following the procedure of Good Manufacturing Practice (GMP). FinVector is internationally recognized and is a pioneer in its operational field.Finvector works on the cutting-edge biopharmaceuticals and we’ve invested into building state-of-the-art development and GMP facilities for Viral Vector and Cell Therapy platforms including vaccines. Our research and development agenda is focused on the most commonly used gene therapy vectors: adenoviral, adeno-associated viral (AAV) and lentiviral vectors and innovative cell therapies.  FinVector offers a versatile and responsible work environment and the work is done together with a group of professionals from various fields. FinVector is owned by Ferring Ventures and we are located in Kuopio, Finland.

Hot jobs

Technician's positions in our Manufacturing department (US, DS, Buffer, Drug Product -teams)

Company details
Contact details: Microkatu 1 S FI-70210 Kuopio , Finland +358 (0)17 240 875

Event participation(s)
05 October 2022
Participating: Online